What is Interscope?
Interscope is a specialized medical device innovator focused on the development of the EndoRotor, a sophisticated tool engineered for complex endoscopic procedures. The company addresses critical gaps in current gastrointestinal care, specifically targeting challenges such as endoscopic necrosectomy and the management of post-resection scarred lesions. By providing gastroenterologists with enhanced precision and efficacy, Interscope occupies a vital niche in the therapeutic endoscopy market. Its operational model integrates rigorous clinical research with iterative product design, ensuring that its solutions meet the evolving demands of modern surgical environments and patient care standards.
How much funding has Interscope raised?
Interscope has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Interscope
PPP
Public-Private Partnership
What's next for Interscope?
With the infusion of this latest capital, Interscope is poised to transition into a phase of aggressive market expansion and clinical validation. The strategic focus will likely center on scaling the distribution of the EndoRotor, while simultaneously investing in long-term clinical studies to broaden the device's application scope. As the company navigates this late-stage growth cycle, the emphasis will remain on securing deeper market penetration among specialized medical centers and establishing the EndoRotor as a standard-of-care instrument. This financial milestone provides the necessary runway to solidify Interscope's competitive advantage and drive sustainable value in the global interventional medical device landscape.
See full Interscope company page
